From FDA meeting preparation to new drug application submission, CCSF has the relevant regulatory expertise to guide sponsors through the entire drug, device, and diagnostic approval process. Our regulatory consulting services include:


  • FDA meeting preparation

  • Scientific/academic representation at FDA (IND, IDE, NDA)

  • Assistance with CDISC compliance

  • Filing IND, IDE, NDA

  • Full suite of management systems for site regulatory affairs


With both industry and FDA advisory committee experience, our thought leaders deliver impactful regulatory insight for sponsors at all stages of drug, device, and diagnostic development.

Dr. Marvin Konstam

  • Former member of FDA Cardiovascular and Renal Drugs Advisory Committee [4 years]

  • Former Senior Adviser, Division of Cardiovascular Diseases, National Heart Lung and Blood Institute

  • Former Chief Medical Officer, Heart Failure Biotechnology Firm


Dr. James Udelson

  • Former member of FDA’s Medical Imaging Drug Advisory Committee [4 years]

  • Former ad-hoc Member, FDA Cardiovascular and Renal Drugs Advisory Panel, Peripheral and Central Nervous System Advisory Panel


Curious how we can help you navigate your innovations from bench to bedside? Request a capabilities presentation, and hear it directly from our experts.



Experts You Know. Results You Trust. 

Cardiovascular Clinical Science Foundation Logo




P: (617) 423-7999 | F: (617) 423-9766 | E:

A75 Kneeland St, Suite 702 | Boston, MA 02111, USA

Privacy Policy | Cookie Statement


Copyright 2017 Cardiovascular Clinical Science Foundation
All Rights Reserved